{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T07:47:35Z","timestamp":1740124055986,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T00:00:00Z","timestamp":1461888000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014382","name":"IPSEN PHARMA","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100014382","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pituitary"],"published-print":{"date-parts":[[2016,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction<\/jats:title>\n            <jats:p>Acromegaly is a rare disease with a large burden due its associated comorbidities and the life-long management required. Since the occurrence and severity of associated complications are related to length of exposure to the excess growth hormone seen in acromegaly, early diagnosis is imperative. The delay in diagnosis, however, can be long, and may be the result of a lack of disease awareness and screening programs. Since acromegaly is an uncommon disease, finding ways to increase recognition and diagnosis that would permit early detection in a logical and cost-effective manner could be a challenge.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a retrospective literature review for information relating to the screening and diagnosis of acromegaly using PubMed. The aim was to assess whether an acromegaly-screening program in Latin America (and elsewhere) would be both of use and be feasible.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Findings and conclusions<\/jats:title>\n            <jats:p>An earlier diagnosis allows earlier initiation of treatment, such as surgery and\/or drugs, which leads to more successful disease management (biochemical control) and better outcomes. Since the delay in diagnosis can be long, we believe that clear opportunities exist for earlier (and increased) detection of acromegaly. This can be achieved by increasing disease awareness for earlier recognition of symptoms and by using targeted screening (rather than mass screening) programs.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s11102-016-0714-5","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T05:57:11Z","timestamp":1461909431000},"page":"370-374","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Implementing a screening program for acromegaly in Latin America: necessity versus feasibility"],"prefix":"10.1007","volume":"19","author":[{"given":"Karina","family":"Danilowicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Fainstein","family":"Day","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos P.","family":"Manavela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Javier","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Laura","family":"Deheza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Isaac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Juri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debora","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oscar D.","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,29]]},"reference":[{"key":"714_CR1","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2147\/IJGM.S38594","volume":"6","author":"DT Adelman","year":"2013","unstructured":"Adelman DT, Liebert KJ, Nachtigall LB, Lamerson M, Bakker B (2013) Acromegaly: the disease, its impact on patients, and managing the burden of long-term treatment. Int J Gen Med 6:31\u201338","journal-title":"Int J Gen Med"},{"issue":"11","key":"714_CR2","doi-asserted-by":"publisher","first-page":"3189","DOI":"10.1172\/JCI39375","volume":"119","author":"S Melmed","year":"2009","unstructured":"Melmed S (2009) Acromegaly pathogenesis and treatment. J Clin Invest 119(11):3189\u20133202","journal-title":"J Clin Invest"},{"issue":"3","key":"714_CR3","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-2265.2008.03221.x","volume":"69","author":"HJ Schneider","year":"2008","unstructured":"Schneider HJ, Sievers C, Saller B, Wittchen HU, Stalla GK (2008) High prevalence of biochemical acromegaly in primary care patients with elevated IGF-1 levels. Clin Endocrinol (Oxf) 69(3):432\u2013435","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"3","key":"714_CR4","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11102-011-0310-7","volume":"14","author":"A Ben-Shlomo","year":"2011","unstructured":"Ben-Shlomo A, Sheppard MC, Stephens JM, Pulgar S, Melmed S (2011) Clinical, quality of life, and economic value of acromegaly disease control. Pituitary 14(3):284\u2013294","journal-title":"Pituitary"},{"key":"714_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1750-1172-3-17","volume":"3","author":"P Chanson","year":"2008","unstructured":"Chanson P, Salenave S (2008) Acromegaly. Orphanet J Rare Dis 3:17","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"714_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.beem.2009.05.010","volume":"23","author":"P Chanson","year":"2009","unstructured":"Chanson P, Salenave S, Kamenicky P, Cazabat L, Young J (2009) Pituitary tumours: acromegaly. Best Pract Res Clin Endocrinol Metab 23(5):555\u2013574","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"714_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1210\/jc.2003-031199","volume":"89","author":"IM Holdaway","year":"2004","unstructured":"Holdaway IM, Rajasoorya RC, Gamble GD (2004) Factors influencing mortality in acromegaly. J Clin Endocrinol Metab 89(2):667\u2013674","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"714_CR8","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1210\/er.2002-0022","volume":"25","author":"A Colao","year":"2004","unstructured":"Colao A, Ferone D, Marzullo P, Lombardi G (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocr Rev 25(1):102\u2013152","journal-title":"Endocr Rev"},{"issue":"1","key":"714_CR9","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","volume":"41","author":"C Rajasoorya","year":"1994","unstructured":"Rajasoorya C, Holdaway IM, Wrightson P, Scott DJ, Ibbertson HK (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf) 41(1):95\u2013102","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"714_CR10","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1210\/jc.2007-1191","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"Dekkers OM, Biermasz NR, Pereira AM, Romijn JA, Vandenbroucke JP (2008) Mortality in acromegaly: a metaanalysis. J Clin Endocrinol Metab 93(1):61\u201367","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"714_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2265.2009.03626.x","volume":"72","author":"TJ Reid","year":"2010","unstructured":"Reid TJ, Post KD, Bruce JN, Nabi Kanibir M, Reyes-Vidal CM, Freda PU (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clin Endocrinol (Oxf) 72(2):203\u2013208","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"714_CR12","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11102-012-0447-z","volume":"16","author":"S Siegel","year":"2013","unstructured":"Siegel S, Streetz-van der Werf C, Schott JS, Nolte K, Karges W, Kreitschmann-Andermahr I (2013) Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary 16(4):507\u2013514","journal-title":"Pituitary"},{"issue":"1","key":"714_CR13","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1210\/jcem-67-1-69","volume":"67","author":"AL Barkan","year":"1988","unstructured":"Barkan AL, Beitins IZ, Kelch RP (1988) Plasma insulin-like growth factor-I\/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion. J Clin Endocrinol Metab 67(1):69\u201373","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"714_CR14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11154-007-9062-0","volume":"9","author":"A Colao","year":"2008","unstructured":"Colao A, Auriemma RS, Pivonello R, Galdiero M, Lombardi G (2008) Medical consequences of acromegaly: what are the effects of biochemical control? Rev Endocr Metab Disord 9(1):21\u201331","journal-title":"Rev Endocr Metab Disord"},{"issue":"5","key":"714_CR15","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1097\/00005792-199409000-00001","volume":"73","author":"S Ezzat","year":"1994","unstructured":"Ezzat S, Forster MJ, Berchtold P, Redelmeier DA, Boerlin V, Harris AG (1994) Acromegaly. Clinical and biochemical features in 500 patients. Medicine (Baltim) 73(5):233\u2013240","journal-title":"Medicine (Baltim)"},{"issue":"24","key":"714_CR16","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1056\/NEJMra062453","volume":"355","author":"S Melmed","year":"2006","unstructured":"Melmed S (2006) Medical progress: acromegaly. N Engl J Med 355(24):2558\u20132573","journal-title":"N Engl J Med"},{"issue":"4","key":"714_CR17","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1530\/eje.0.1510439","volume":"151","author":"A Mestron","year":"2004","unstructured":"Mestron A, Webb SM, Astorga R, Benito P, Catala M, Gaztambide S, Gomez JM, Halperin I, Lucas-Morante T, Moreno B, Obiols G, de Pablos P, Paramo C, Pico A, Torres E, Varela C, Vazquez JA, Zamora J, Albareda M, Gilabert M (2004) Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA). Eur J Endocrinol 151(4):439\u2013446","journal-title":"Eur J Endocrinol"},{"key":"714_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/acprof:oso\/9780199214495.001.0001","volume-title":"Screening: evidence and practice","author":"AE Raffe","year":"2007","unstructured":"Raffe AE, Gray M (2007) Screening: evidence and practice. Oxford University Press, Oxford"},{"issue":"4","key":"714_CR19","first-page":"281","volume":"65","author":"JM Wilson","year":"1968","unstructured":"Wilson JM, Jungner YG (1968) Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 65(4):281\u2013393","journal-title":"Bol Oficina Sanit Panam"},{"issue":"9","key":"714_CR20","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1056\/NEJMclde1301407","volume":"368","author":"JA Colbert","year":"2013","unstructured":"Colbert JA, Adler JN (2013) Clinical decisions. Mammography screening\u2013polling results. N Engl J Med 368(9):e12","journal-title":"N Engl J Med"},{"issue":"7","key":"714_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.7326\/0003-4819-156-7-201204030-00005","volume":"156","author":"M Kalager","year":"2012","unstructured":"Kalager M, Adami HO, Bretthauer M, Tamimi RM (2012) Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program. Ann Intern Med 156(7):491\u2013499","journal-title":"Ann Intern Med"},{"issue":"24","key":"714_CR22","first-page":"2355","volume":"369","author":"A Shaukat","year":"2013","unstructured":"Shaukat A, Church TR (2013) Colorectal-cancer incidence and mortality after screening. N Engl J Med 369(24):2355","journal-title":"N Engl J Med"},{"issue":"12","key":"714_CR23","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1056\/NEJMoa1300720","volume":"369","author":"A Shaukat","year":"2013","unstructured":"Shaukat A, Mongin SJ, Geisser MS, Lederle FA, Bond JH, Mandel JS, Church TR (2013) Long-term mortality after screening for colorectal cancer. N Engl J Med 369(12):1106\u20131114","journal-title":"N Engl J Med"},{"issue":"15","key":"714_CR24","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/jama.2009.1498","volume":"302","author":"L Esserman","year":"2009","unstructured":"Esserman L, Shieh Y, Thompson I (2009) Rethinking screening for breast cancer and prostate cancer. JAMA 302(15):1685\u20131692","journal-title":"JAMA"},{"issue":"21","key":"714_CR25","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1056\/NEJMcp1103642","volume":"365","author":"RM Hoffman","year":"2011","unstructured":"Hoffman RM (2011) Clinical practice. Screening for prostate cancer. N Engl J Med 365(21):2013\u20132019","journal-title":"N Engl J Med"},{"issue":"3","key":"714_CR26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.7326\/0003-4819-113-3-214","volume":"113","author":"DM Eddy","year":"1990","unstructured":"Eddy DM (1990) Screening for cervical cancer. Ann Intern Med 113(3):214\u2013226","journal-title":"Ann Intern Med"},{"key":"714_CR27","volume-title":"Medical statistics at a glance","author":"A Petrie","year":"2000","unstructured":"Petrie A, Sabin C (2000) Medical statistics at a glance. Blackwell Science, Hoboken"},{"issue":"2","key":"714_CR28","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11102-011-0302-7","volume":"15","author":"PW Rosario","year":"2012","unstructured":"Rosario PW, Calsolari MR (2012) Screening for acromegaly by application of a simple questionnaire evaluating the enlargement of extremities in adult patients seen at primary health care units. Pituitary 15(2):179\u2013183","journal-title":"Pituitary"},{"issue":"2","key":"714_CR29","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1111\/j.1365-2265.2011.04020.x","volume":"75","author":"RE Miller","year":"2011","unstructured":"Miller RE, Learned-Miller EG, Trainer P, Paisley A, Blanz V (2011) Early diagnosis of acromegaly: computers vs clinicians. Clin Endocrinol (Oxf) 75(2):226\u2013231","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"7","key":"714_CR30","doi-asserted-by":"publisher","first-page":"2074","DOI":"10.1210\/jc.2011-0237","volume":"96","author":"HJ Schneider","year":"2011","unstructured":"Schneider HJ, Kosilek RP, Gunther M, Roemmler J, Stalla GK, Sievers C, Reincke M, Schopohl J, Wurtz RP (2011) A novel approach to the detection of acromegaly: accuracy of diagnosis by automatic face classification. J Clin Endocrinol Metab 96(7):2074\u20132080","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"714_CR31","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1210\/jc.2007-2149","volume":"93","author":"L Nachtigall","year":"2008","unstructured":"Nachtigall L, Delgado A, Swearingen B, Lee H, Zerikly R, Klibanski A (2008) Changing patterns in diagnosis and therapy of acromegaly over two decades. J Clin Endocrinol Metab 93(6):2035\u20132041","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Pituitary"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-016-0714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11102-016-0714-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-016-0714-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11102-016-0714-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T20:13:00Z","timestamp":1630613580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11102-016-0714-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,29]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["714"],"URL":"https:\/\/doi.org\/10.1007\/s11102-016-0714-5","relation":{},"ISSN":["1386-341X","1573-7403"],"issn-type":[{"type":"print","value":"1386-341X"},{"type":"electronic","value":"1573-7403"}],"subject":[],"published":{"date-parts":[[2016,4,29]]},"assertion":[{"value":"29 April 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}